Different effects of methotrexate on DNA mismatch repair proficient and deficient cells

被引:19
作者
Frouin, I
Prosperi, E
Denegri, M
Negri, C
Donzelli, M
Rossi, L
Riva, F
Stefanini, M
Scovassi, AI
机构
[1] CNR, Ist Genet Biochim & Evoluzionist, I-27100 Pavia, Italy
[2] CNR, Ctr Studio Istochim, I-27100 Pavia, Italy
关键词
methotrexate; DNA mismatch repair; base excision repair; apoptosis; PCNA;
D O I
10.1016/S0959-8049(01)00095-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Antifolates exert their antiproliferative activity through the inhibition of dihydrofolate reductase and, as a consequence, of thymidylate synthesis, thereby inducing nucleotide misincorporation and impairment of DNA synthesis. We investigated the processes involved in the repair of antifolate-induced damage and their relationship with cell death. Since misincorporated bases may be removed by DNA mismatch repair (MMR), the study was carried out on the MMR-proficient human cell lines HeLa and HCT116 + chr3, and, in parallel, on the MMR-deficient cell lines HeLa cell-clone12, defective in the protein hPMS2, and HCT116, with an inactive hMLH1. After treatment with methotrexate (MTX), we observed that DNA repair synthesis occurs independently of the cellular MMR function. Clear signs of apoptosis such as nuclear shrinkage, chromatin condensation and degradation, DNA laddering, and poly (ADP-ribose) polymerase (PARP) proteolysis, were visible in both MMR+ and MMR- cells. Remarkably, cell viability was lower and the apoptotic process was triggered more efficiently in the MMR-competent cells. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1173 / 1180
页数:8
相关论文
共 31 条
[1]  
Aquilina G, 2000, CLIN CANCER RES, V6, P671
[2]   Mismatch repair proficiency and in vitro response to 5-fluorouracil [J].
Carethers, JM ;
Chauhan, DP ;
Fink, D ;
Nebel, S ;
Bresalier, RS ;
Howell, SB ;
Boland, CR .
GASTROENTEROLOGY, 1999, 117 (01) :123-131
[3]   Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine [J].
Carethers, JM ;
Hawn, MT ;
Chauhan, DP ;
Luce, MC ;
Marra, G ;
Koi, M ;
Boland, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :199-206
[4]   Processing of O-6-methylguanine by mismatch correction in human cell extracts [J].
Ceccotti, S ;
Aquilina, G ;
Macpherson, P ;
Yamada, M ;
Karran, P ;
Bignami, M .
CURRENT BIOLOGY, 1996, 6 (11) :1528-1531
[5]   Increased somatic recombination in methylation tolerant human cells with defective DNA mismatch repair [J].
Ciotta, C ;
Ceccotti, S ;
Aquilina, G ;
Humbert, O ;
Palombo, F ;
Jiricny, J ;
Bignami, M .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 276 (04) :705-719
[6]   Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents [J].
Colella, G ;
Marchini, S ;
D'Incalci, MD ;
Brown, R ;
Broggini, M .
BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) :338-343
[7]   Involvement of the mismatch repair system in temozolomide-induced apoptosis [J].
D'Atri, S ;
Tentori, L ;
Lacal, PM ;
Graziani, G ;
Pagani, E ;
Benincasa, E ;
Zambruno, G ;
Bonmassar, E ;
Jiricny, J .
MOLECULAR PHARMACOLOGY, 1998, 54 (02) :334-341
[8]  
Davis TW, 1998, CANCER RES, V58, P767
[9]   Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene [J].
Donzelli, M ;
Bernardi, R ;
Negri, C ;
Prosperi, E ;
Padovan, L ;
Lavialle, C ;
Brison, O ;
Scovassi, AI .
ONCOGENE, 1999, 18 (02) :439-448
[10]   Two pathways for base excision repair in mammalian cells [J].
Frosina, G ;
Fortini, P ;
Rossi, O ;
Carrozzino, F ;
Raspaglio, G ;
Cox, LS ;
Lane, DP ;
Abbondandolo, A ;
Dogliotti, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (16) :9573-9578